MOPA — Medical Oncology Prior Authorization
0.1.1-snapshot-080926 - snapshot-080926 United States of America flag

MOPA — Medical Oncology Prior Authorization - Local Development build (v0.1.1-snapshot-080926) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

: Example: CDS Hooks order-sign draftOrders Bundle (TH regimen)

Raw json | Download

{
  "resourceType" : "Bundle",
  "id" : "ExampleOrderSignBundle",
  "language" : "en",
  "type" : "collection",
  "entry" : [
    {
      "fullUrl" : "http://hl7.org/fhir/us/codex-mopa/RequestGroup/THRegimenOrder",
      "resource" : {
        "resourceType" : "RequestGroup",
        "id" : "THRegimenOrder",
        "meta" : {
          "profile" : [
            🔗 "http://hl7.org/fhir/us/codex-mopa/StructureDefinition/anticancer-regimen-requestgroup"
          ]
        },
        "language" : "en",
        "text" : {
          "status" : "extensions",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: RequestGroup THRegimenOrder</b></p><a name=\"THRegimenOrder\"> </a><a name=\"hcTHRegimenOrder\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-anticancer-regimen-requestgroup.html\">Anti-Cancer Regimen RequestGroup</a></p></div><p><b>Request Category</b>: <span title=\"Codes:{http://snomed.info/sct 373846009}\">Adjuvant - intent</span></p><p><b>Request Category</b>: <span title=\"Codes:{http://hl7.org/fhir/us/codex-mopa/CodeSystem/treatment-line-cs 1L}\">First-line</span></p><p><b>instantiatesCanonical</b>: <a href=\"PlanDefinition-RegimenTH.html\">TH: Paclitaxel + Trastuzumab (Weekly) — HER2+ Breast Cancer</a></p><p><b>status</b>: Draft</p><p><b>intent</b>: Order</p><p><b>subject</b>: <a href=\"Patient-MOPAPatientExample.html\">Jane Smith (official) Female, DoB: 1968-04-15 ( http://hospital.example.org/patients#MRN-78432)</a></p><blockquote><p><b>action</b></p><blockquote><p><b>id</b></p>paclitaxel-th-action</blockquote><p><b>title</b>: Paclitaxel 80 mg/m² IV — days 1, 8, 15 of 21-day cycle</p><p><b>timing</b>: Once per 21 days</p><p><b>resource</b>: <a href=\"MedicationRequest-PaclitaxelMedRequestTH.html\">MedicationRequest: status = draft; intent = order; medication[x] = paclitaxel</a></p></blockquote><blockquote><p><b>action</b></p><blockquote><p><b>id</b></p>trastuzumab-th-action</blockquote><p><b>title</b>: Trastuzumab IV — days 1, 8, 15 of 21-day cycle</p><p><b>timing</b>: Once per 21 days</p><p><b>resource</b>: <a href=\"MedicationRequest-TrastuzumabMedRequestTH.html\">MedicationRequest: status = draft; intent = order; medication[x] = trastuzumab</a></p></blockquote></div>"
        },
        "extension" : [
          {
            "url" : "http://hl7.org/fhir/us/davinci-crd/StructureDefinition/ext-request-category",
            "valueCodeableConcept" : {
              "coding" : [
                {
                  "system" : "http://snomed.info/sct",
                  "code" : "373846009",
                  "display" : "Adjuvant - intent"
                }
              ]
            }
          },
          {
            "url" : "http://hl7.org/fhir/us/davinci-crd/StructureDefinition/ext-request-category",
            "valueCodeableConcept" : {
              "coding" : [
                {
                  "system" : "http://hl7.org/fhir/us/codex-mopa/CodeSystem/treatment-line-cs",
                  "code" : "1L",
                  "display" : "First-line"
                }
              ]
            }
          }
        ],
        "instantiatesCanonical" : [
          🔗 "http://hl7.org/fhir/us/codex-mopa/PlanDefinition/RegimenTH"
        ],
        "status" : "draft",
        "intent" : "order",
        "subject" : {
          🔗 "reference" : "Patient/MOPAPatientExample"
        },
        "action" : [
          {
            "id" : "paclitaxel-th-action",
            "title" : "Paclitaxel 80 mg/m² IV — days 1, 8, 15 of 21-day cycle",
            "timingTiming" : {
              "extension" : [
                {
                  "extension" : [
                    {
                      "url" : "day",
                      "valueInteger" : 1
                    },
                    {
                      "url" : "day",
                      "valueInteger" : 8
                    },
                    {
                      "url" : "day",
                      "valueInteger" : 15
                    }
                  ],
                  "url" : "http://hl7.org/fhir/us/codex-mopa/StructureDefinition/regimen-days-of-cycle"
                }
              ],
              "repeat" : {
                "period" : 21,
                "periodUnit" : "d"
              }
            },
            "resource" : {
              🔗 "reference" : "MedicationRequest/PaclitaxelMedRequestTH"
            }
          },
          {
            "id" : "trastuzumab-th-action",
            "title" : "Trastuzumab IV — days 1, 8, 15 of 21-day cycle",
            "timingTiming" : {
              "extension" : [
                {
                  "extension" : [
                    {
                      "url" : "day",
                      "valueInteger" : 1
                    },
                    {
                      "url" : "day",
                      "valueInteger" : 8
                    },
                    {
                      "url" : "day",
                      "valueInteger" : 15
                    }
                  ],
                  "url" : "http://hl7.org/fhir/us/codex-mopa/StructureDefinition/regimen-days-of-cycle"
                }
              ],
              "repeat" : {
                "period" : 21,
                "periodUnit" : "d"
              }
            },
            "resource" : {
              🔗 "reference" : "MedicationRequest/TrastuzumabMedRequestTH"
            }
          }
        ]
      }
    },
    {
      "fullUrl" : "http://hl7.org/fhir/us/codex-mopa/MedicationRequest/PaclitaxelMedRequestTH",
      "resource" : {
        "resourceType" : "MedicationRequest",
        "id" : "PaclitaxelMedRequestTH",
        "meta" : {
          "profile" : [
            🔗 "http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-request"
          ]
        },
        "language" : "en",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: MedicationRequest PaclitaxelMedRequestTH</b></p><a name=\"PaclitaxelMedRequestTH\"> </a><a name=\"hcPaclitaxelMedRequestTH\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"http://hl7.org/fhir/us/mcode/STU4/StructureDefinition-mcode-cancer-related-medication-request.html\">Cancer-Related Medication Request Profile</a></p></div><p><b>status</b>: Draft</p><p><b>intent</b>: Order</p><p><b>medication</b>: <span title=\"Codes:{http://www.nlm.nih.gov/research/umls/rxnorm 56946}\">paclitaxel</span></p><p><b>subject</b>: <a href=\"Patient-MOPAPatientExample.html\">Jane Smith (official) Female, DoB: 1968-04-15 ( http://hospital.example.org/patients#MRN-78432)</a></p><p><b>requester</b>: <a href=\"Practitioner-MOPAOncologistExample.html\">Practitioner Maria Lopez (official)</a></p><p><b>reasonReference</b>: <a href=\"Condition-MOPABreastCancerConditionExample.html\">Condition Malignant neoplasm of breast</a></p><h3>DosageInstructions</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Text</b></td></tr><tr><td style=\"display: none\">*</td><td>80 mg/m² IV over 1 hour, weekly</td></tr></table></div>"
        },
        "status" : "draft",
        "intent" : "order",
        "medicationCodeableConcept" : {
          "coding" : [
            {
              "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
              "code" : "56946",
              "display" : "paclitaxel"
            }
          ]
        },
        "subject" : {
          🔗 "reference" : "Patient/MOPAPatientExample"
        },
        "requester" : {
          🔗 "reference" : "Practitioner/MOPAOncologistExample"
        },
        "reasonReference" : [
          {
            🔗 "reference" : "Condition/MOPABreastCancerConditionExample"
          }
        ],
        "dosageInstruction" : [
          {
            "text" : "80 mg/m² IV over 1 hour, weekly"
          }
        ]
      }
    },
    {
      "fullUrl" : "http://hl7.org/fhir/us/codex-mopa/MedicationRequest/TrastuzumabMedRequestTH",
      "resource" : {
        "resourceType" : "MedicationRequest",
        "id" : "TrastuzumabMedRequestTH",
        "meta" : {
          "profile" : [
            🔗 "http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-request"
          ]
        },
        "language" : "en",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: MedicationRequest TrastuzumabMedRequestTH</b></p><a name=\"TrastuzumabMedRequestTH\"> </a><a name=\"hcTrastuzumabMedRequestTH\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"http://hl7.org/fhir/us/mcode/STU4/StructureDefinition-mcode-cancer-related-medication-request.html\">Cancer-Related Medication Request Profile</a></p></div><p><b>status</b>: Draft</p><p><b>intent</b>: Order</p><p><b>medication</b>: <span title=\"Codes:{http://www.nlm.nih.gov/research/umls/rxnorm 224905}\">trastuzumab</span></p><p><b>subject</b>: <a href=\"Patient-MOPAPatientExample.html\">Jane Smith (official) Female, DoB: 1968-04-15 ( http://hospital.example.org/patients#MRN-78432)</a></p><p><b>requester</b>: <a href=\"Practitioner-MOPAOncologistExample.html\">Practitioner Maria Lopez (official)</a></p><p><b>reasonReference</b>: <a href=\"Condition-MOPABreastCancerConditionExample.html\">Condition Malignant neoplasm of breast</a></p><h3>DosageInstructions</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Text</b></td></tr><tr><td style=\"display: none\">*</td><td>4 mg/kg IV loading dose week 1, then 2 mg/kg IV weekly</td></tr></table></div>"
        },
        "status" : "draft",
        "intent" : "order",
        "medicationCodeableConcept" : {
          "coding" : [
            {
              "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
              "code" : "224905",
              "display" : "trastuzumab"
            }
          ]
        },
        "subject" : {
          🔗 "reference" : "Patient/MOPAPatientExample"
        },
        "requester" : {
          🔗 "reference" : "Practitioner/MOPAOncologistExample"
        },
        "reasonReference" : [
          {
            🔗 "reference" : "Condition/MOPABreastCancerConditionExample"
          }
        ],
        "dosageInstruction" : [
          {
            "text" : "4 mg/kg IV loading dose week 1, then 2 mg/kg IV weekly"
          }
        ]
      }
    }
  ]
}